Ulinastatin showed signals for improving outcomes in post-traumatic sepsis, with a randomized trial reporting shorter ICU and hospital stays and better inflammatory markers, while 28-day mortality did not differ significantly. The dataset points to supportive-care value rather than a definitive mortality-driving effect. A separate large review found that AI-driven MRI screening for Alzheimer’s disease signs can reach pooled accuracy near 0.9, but results showed substantial heterogeneity, limited external validation, and frequent risk-of-bias concerns. That caution has immediate relevance for deployment in clinical workflows. Finally, a matched case–control study reported that delays after open-globe injury raise endophthalmitis risk, with each doubling of the injury-to-admission interval linked to higher adjusted odds—reinforcing the operational importance of rapid care pathways.